Skip to main content
search
Category

Regulatory Affairs Newsletter

UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA weekly update (WC 13 Nov)

Please note this is an extract of the original bulletin. MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia Page summary: Casgevy (exagamglogene autotemcel) is based on the innovative gene-editing tool CRISPR, which won its inventors the Nobel Prize in 2020 Change made: First published.  
admin
November 24, 2023
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DSIT weekly update (WC 13 Nov)

Please note this is an extract of the original bulletin. UK Innovation Strategy: leading the future by creating it Page summary: This strategy sets our ambitions for an innovation-led economy. Change made: Linked ‘National digital twin programme (NDTP)’ to its collection page. 2,500 new places on artificial intelligence and data science conversion courses now open to applicants Page summary: Government…
admin
November 24, 2023
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DBT weekly update (WC 13 Nov)

Please note this is an extract of the original bulletin. Reference documents for Customs (Additional Duty) (Russia and Belarus) Regulations 2022 Page summary: Find out about the additional duties which apply on certain goods originating from Russia and Belarus. Change made: Update of the Russian and Belarusian additional duties documents to version 1.4. Additional duties on goods originating in Russia…
admin
November 24, 2023
Industry Newsletters Regulatory Affairs NewsletterIndustry Newsletters Regulatory Affairs Newsletter ArchiveUpcoming Events Regulatory Affairs NewsletterUpcoming Events Regulatory Affairs Newsletter Archive

BSI webinar on EU IVDR regulatory updates

BSI are hosting a webinar about the latest IVDR regulatory updates on 28 November. The webinar will include a short recap on where the IVDR is, along with latest MDCG guidance and developments in Brussels; description of the challenges for Class D IVD’s and the status on EU Reference Labs and envision the potential ramifications for manufacturers of these updates.…
admin
November 24, 2023
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA weekly update (WC 06 Nov)

Please note this is an extract of the original bulletin. Access Consortium Page summary: The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic. Change made: Added details of the Access Consortium’s Advanced Therapy Medicinal Products Working Group. Medical devices given exceptional use authorisations during the COVID-19…
admin
November 17, 2023
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DSIT weekly update (WC 06 Nov)

Please note this is an extract of the original bulletin. Biomanufacturing Fund (BMF): phase 2 open to expressions of interest Page summary: This fund is to support commercial-scale vaccines and biotherapeutics manufacturing projects that will improve the UK’s health resilience for future pandemics. Change made: Deadline to submit a Expression of Interest (EOI) form changed to 12pm (midday) on Friday…
admin
November 17, 2023
Close Menu